Skip to main content
. 2015 May 1;15(10):1–64.

Table 26:

Recommendations by Urological Societies on PSA Testing for Prostate Cancer

Society, Year Recommendation Summary
American Urological Association, 2013 (92)
  • does not recommend routine PSA screening in men age < 40 years.

  • does not recommend routine PSA screening in men age 40–54 years at average risk

  • recommends shared decision-making in men age 55–69 years

  • states that, to reduce harms, a routine screening interval of 2 years or more may be preferred over annual screening in those men who have participated in shared decision-making and decided on screening

  • does not recommend PSA screening in men age > 70 years or in men with life expectancy < 10–15 years

Canadian Urological Association, 2011 (95)
  • recommends PSA screening be offered to all men age 50 years or older with a life expectancy of at least 10 years

  • states that harms and benefits of PC screening must be explained to each patient so they understand the factors to be considered in the shared decision-making about screening

European Association of Urology, 2013 (93)
  • does not recommend mass screening for PC but does recommend early detection in well-informed men

Abbreviations: PC, prostate cancer; PSA, prostate specific antigen.